The Procter & Gamble Company

Repeat-purchase essentials (detergent, diapers, razors, toothpaste) with leading market shares in most categories generate highly recurring, if non-contractual, demand. P&G delivered six consecutive years of 4%+ organic sales growth through FY2025, though Q2 FY2026 volume fell 1% and FY2026 EPS guidance was lowered to 1-6% from 3-9%.

Five reportable segments in FY2025: Fabric & Home Care $29.6B (35%), Baby/Feminine/Family Care $20.3B (24%), Beauty $15.0B (18%), Health Care $12.0B (14%), Grooming $6.7B (8%). No segment above ~36%, but laundry/home care concentration and shared retail distribution limit independence of end markets.

Operates in ~70 countries with Greater China, UK, Canada, Japan, and Germany collectively ~21% of FY2025 net sales. North America remains the single largest revenue source at roughly half of sales, leaving meaningful but not balanced global spread; FX headwinds to FY2025 sales reflect this exposure.

Branded CPG carries fixed marketing and R&D that levers over volume, but the model is structurally capex- and inventory-intensive with physical manufacturing in roughly 70 countries. Operating margin has held in the low-to-mid 20s across recent fiscal years rather than expanding sharply, reflecting the cap on operating leverage.

Mission-critical household staples with entrenched repeat-purchase behavior; demand proved resilient through the 2008 crisis and surged in 2020. Revenue is transactional, not subscription, and carries no multi-year contractual duration — which is the ceiling keeping this a defensive but not contracted book.